Maxime CULOT Tel: 03 21 79 17 51 |
Dr. Maxime Culot is presently professor at the Faculty of Sciences, University of Artois, Lens, France, where he received his Ph.D. in 2007. During his thesis he participated in a research program with AstraZeneca aimed at both identifying molecular mechanisms underlying BBB dysfunction in stroke and investigating neurovascular protective actions of various compounds through the use of different in vitro BBB models, proteomics and cells from knock-out animals. He was also involved in the development of a new in vitro model of the BBB adapted to the screening of large number of compounds and contributed to several research contracts with pharmaceutical compagnies.In his actual position he is responsible for pharmaceutical and toxicological applications of cell and tissue culture.Maxime participated in several EU-funded projects (FP7:Predict iv; H2020-ITN: BtRAIN; in3; EuroNanomed: DiaSyn; H2020-Eurostar: G2B).He is the coordinator of the Master Tox & Ecotox program “MENACE” which focus on New Approach Methodologies (NAMs).His current focus is to study xenobiotics transport across biological barriers using human stem cell derived in vitro models.
